CAMBRIDGE, MA—Mersana Therapeutics, Inc. (NASDAQ:MRSN), currently trading near its 52-week low of $0.56, recently disclosed ...
Bala Mohan, the Senior Vice President and Chief Development Officer at Mersana Therapeutics, Inc. (NASDAQ:MRSN), recently ...
Expectations for a pro-business climate under the incoming Trump administration has lifted the spirits of major bank ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback